1. Home
  2. HTZ vs NVCR Comparison

HTZ vs NVCR Comparison

Compare HTZ & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$5.55

Market Cap

1.7B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.47

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZ
NVCR
Founded
1918
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
HTZ
NVCR
Price
$5.55
$13.47
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$5.05
$26.42
AVG Volume (30 Days)
5.2M
1.0M
Earning Date
02-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,516,000,000.00
$642,269,000.00
Revenue This Year
N/A
$9.68
Revenue Next Year
$3.35
$6.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.17
52 Week Low
$3.26
$10.70
52 Week High
$9.39
$27.32

Technical Indicators

Market Signals
Indicator
HTZ
NVCR
Relative Strength Index (RSI) 51.65 49.97
Support Level $5.33 $12.80
Resistance Level $6.14 $14.29
Average True Range (ATR) 0.32 0.70
MACD 0.02 -0.08
Stochastic Oscillator 36.27 29.14

Price Performance

Historical Comparison
HTZ
NVCR

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: